Perindopril Erbumine
Product Images NDC 10135-599

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Perindopril Erbumine (NDC 10135-599). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Marlex Pharmaceuticals Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

The Structural Formula Of Perindopril Erbumine. (Perindopril Erbumine 01)

Chemical structure of Perindopril Erbumine showing the molecular arrangement including cyclohexane and amide functional groups, carboxyl groups, and various side chains with carbon, hydrogen, nitrogen, and oxygen atoms.*

FDA Label Image

Figure 1. (Perindopril Erbumine 02)

A line graph titled 'Time to First Occurrence of Primary Endpoint' comparing placebo and Perindopril groups over approximately 5 years. The y-axis represents the proportion (%) of patients who had cardiovascular mortality, nonfatal myocardial infarction, or cardiac arrest. Two curves show higher event rates for placebo versus Perindopril, with error bars depicted at several points. Below is a table showing the number of patients at risk for each group at different time intervals.*

FDA Label Image

Figure 2. (Perindopril Erbumine 03)

A forest plot chart showing the beneficial effect of Perindopril treatment on primary endpoint events in predefined subgroups. The chart lists various patient subgroups by sex, age, medical history, and medication use, with primary event percentages for Perindopril and placebo groups. Data points are displayed with squares proportional to subgroup sizes, and a dashed line indicates overall relative risk, comparing Perindopril versus placebo.*

FDA Label Image

Principal Display Panelndc 10135-0599-01perindoprilerbumine Tablets4 mgrx Only100 Tablets (Perindopril Erbumine 04)

Label for Perindopril Erbumine Tablets, 4 mg strength, manufactured by Patheon Pharmaceuticals, Inc. and distributed by Marlex Pharmaceuticals, Inc. The label includes the NDC 10135-0599-01, states the package contains 100 tablets, and provides storage instructions, dosage reference, and warnings to keep out of reach of children. There are designated areas for lot number and expiration date.*

FDA Label Image

Principal Display Panelndc 10135-0600-01perindoprilerbumine Tablets8 mgrx Only100 Tablets (Perindopril Erbumine 05)

Label for Perindopril Erbumine Tablets 8 mg by Marlex Pharmaceuticals Inc. The label indicates a 100-tablet count and includes storage instructions, NDC 10135-0600-01, and manufacturer/distributor information. It states Rx Only and includes barcode and space for lot number and expiration date.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.